Effects of Water-soluble Olive Extract Supplementation

March 23, 2012 updated by: University of Texas at Austin

Effects of Water-soluble Olive Extract on Antioxidant Status, Exercise Performance, Muscle Metabolism, Muscle Damage and Inflammation

Six weeks of supplementation of an olive extract will:

  • Improve antioxidant status
  • Reduce inflammation
  • Reduce muscle damage
  • Improve exercise performance
  • Improve exercise recovery as compared to a placebo.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Austin, Texas, United States, 78712
        • The University of Texas at Austin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Recreational exerciser
  • BMI <= 30
  • Non-smoker

Exclusion Criteria:

  • Blood pressure over 140/90
  • Type I or Type II diabetes
  • Renal, hepatic or cardiac disease
  • Current infectious disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo control
Placebo
Active Comparator: 150mg olive extract
Capsule form ingested 1x/day for 6 weeks
Active Comparator: 50mg olive extract
Capsule form ingested 1x/day for 6 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Improved Antioxidant Status
Time Frame: 6 weeks
6 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Reduced Inflammation
Time Frame: 6 weeks
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John Ivy, Ph.D., The University of Texas at Austin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2010

Primary Completion (Actual)

July 1, 2011

Study Completion (Actual)

February 1, 2012

Study Registration Dates

First Submitted

April 28, 2010

First Submitted That Met QC Criteria

April 29, 2010

First Posted (Estimate)

April 30, 2010

Study Record Updates

Last Update Posted (Estimate)

March 27, 2012

Last Update Submitted That Met QC Criteria

March 23, 2012

Last Verified

February 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 2009-09-01-OLIV

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Placebo

Subscribe